You are here:
Publication details
The Real-World Cost Study of Treating mCRC with Bevacizumab Followed by EGFRi in WT KRAS patients
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation |